Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Vaccine
Review examines the role of antibodies in success of anti-cancer vaccination
February 2nd, 2006
Researchers explore the role of antibodies in the success of anti-cancer vaccination in a recent issue of the journal Breast. According to the review from Switzerland, "The search for target molecules on tumor cells eliciting strong immune responses in cancer patients has been pursued over decades. Growth factors and their respective receptors were discovered as suitable targets for passive or active immunotherapy approaches. Monoclonal antibodies directed against some of these targets like the proto-oncogene HER2/neu have become an accepted standard of therapy in the clinical management of subgroups of HER2/neu overexpressing breast cancer patients and in other...
Source: Women's Health Weekly (2006-02-02)
|
